# Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy

> **NCT06549023** · NA · RECRUITING · sponsor: **Vastra Gotaland Region** · enrollment: 40 (estimated)

## Conditions studied

- Proliferative Diabetic Retinopathy
- Diabetic Retinopathy
- Diabetic Retinopathy Visually Threatening
- Diabetic Macular Edema
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2

## Interventions

- **PROCEDURE:** Single-session panretinal PRP (SS-PRP)
- **PROCEDURE:** Multiple-session panretinal PRP (MS-PRP)

## Key facts

- **NCT ID:** NCT06549023
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06549023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06549023, "Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06549023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*